- $496.56m
- $683.47m
- $578.63m
- 90
- 56
- 50
- 71
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 371 | 367 | 404 | 503 | 579 |
Cost of Revenue | |||||
Gross Profit | 113 | 109 | 121 | 157 | 184 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 342 | 344 | 377 | 471 | 536 |
Operating Profit | 29.4 | 23 | 26 | 31.7 | 42.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 23.8 | 18.8 | 23.1 | 23.7 | 29.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 17 | 13.6 | 24.1 | 17.4 | 24.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 17 | 13.6 | 24.1 | 17.4 | 24.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 17 | 13.6 | 24.1 | 17.4 | 24.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.21 | 0.976 | 1.72 | 1.24 | 1.69 |
Dividends per Share |